MicroRNAs: New therapeutic targets for intestinal barrier dysfunction

World Journal of Gastroenterology

Volumn 20, Issue 19, 2014, Pages 5818-5825

  Zhang, Lin ^a   Cheng, Jian ^a   Fan, Xiao Ming ^a  

^a JINSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Celiac disease; Inflammatory bowel disease; Intestinal barrier dysfunction; MicroRNAs; Therapeutic target

Indexed keywords

MICRORNA; MICRORNA 150; MICRORNA 155; MICRORNA 1792; MICRORNA 181A; MICRORNA 192; MICRORNA 21; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHAGY; CELIAC DISEASE; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CROHN DISEASE; DIGESTIVE SYSTEM DISEASE; GENE CONTROL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINAL BARRIER DYSFUNCTION; INTESTINE EPITHELIUM CELL; MULTIPLE MYELOMA; NONHUMAN; REVIEW; RNA DEGRADATION; ULCERATIVE COLITIS; AUTOIMMUNE DISEASE; GENE EXPRESSION REGULATION; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINE; METABOLISM; MITOCHONDRION; PATHOLOGY; RNA PROCESSING; TIGHT JUNCTION; TREATMENT OUTCOME;

AUTOIMMUNE DISEASES; AUTOPHAGY; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINES; MICRORNAS; MITOCHONDRIA; RNA PROCESSING, POST-TRANSCRIPTIONAL; TIGHT JUNCTIONS; TREATMENT OUTCOME;

EID: 84901217960     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i19.5818     Document Type: Review

References (107)

1. Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis 2009; 27: 443-449 [PMID: 19897958 DOI: 10.1159/000233282]
2. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009; 124: 3-20; quiz 21-22 [PMID: 19560575 DOI: 10.1016/j.jaci.2009.05.038]
3. Groschwitz KR, Ahrens R, Osterfeld H, Gurish MF, Han X, Abrink M, Finkelman FD, Pejler G, Hogan SP. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc Natl Acad Sci USA 2009; 106: 22381-22386 [PMID: 20018751 DOI: 10.1073/pnas.0906372106]
4. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011; 141: 769-776 [PMID: 21430248 DOI: 10.3945/jn.110.135657]
5. Sartor RB. Mechanisms of disease: pathogenesis of Crohn' s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407 [PMID: 16819502 DOI: 10.1038/ncpgasthep0528]
6. Clavel T, Haller D. Bacteria-and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 2007; 13: 1153-1164 [PMID: 17476679 DOI: 10.1002/ibd.20174]
7. Werner T, Haller D. Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanisms. Mutat Res 2007; 622: 42-57 [PMID: 17628614 DOI: 10.1016/j.mrfmmm.2007.05.010]
8. Brandtzaeg P. Update on mucosal immunoglobulin A in gastrointestinal disease. Curr Opin Gastroenterol 2010; 26: 554-563 [PMID: 20693891 DOI: 10.1097/MOG.0b013e32833dccf8]
9. Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008; 57: 591-599 [PMID: 18194983 DOI: 10.1136/gut.2007.140210]
10. Gadewar S, Fasano A. Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol 2005; 5: 559-565 [PMID: 16207535 DOI: 10.1016/j.coph.2005.08.002]
11. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-450 [PMID: 17011485 DOI: 10.1016/j.devcel.2006.09.009]
12. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874 [PMID: 22094949 DOI: 10.1038/ nrg3074]
13. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854 [PMID: 8252621]
14. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007; 8: 93-103 [PMID: 17230196 DOI: 10.1038/nrg1990]
15. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233 [PMID: 19167326 DOI: 10.1016/j.cell.2009.01.002]
16. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37: 766-770 [PMID: 15965474 DOI: 10.1038/ng1590]
17. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20 [PMID: 15652477 DOI: 10.1016/j.cell.2004.12.035]
18. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105 [PMID: 18955434 DOI: 10.1101/ gr.082701.108]
19. Lim LP, Lau NC, Weinstein EG, Abdelhakim A, Yekta S, Rhoades MW, Burge CB, Bartel DP. The microRNAs of Caenorhabditis elegans. Genes Dev 2003; 17: 991-1008 [PMID: 12672692 DOI: 10.1101/gad.1074403]
20. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-4060 [PMID: 15372072 DOI: 10.1038/ sj.emboj.7600385]
21. Zhou X, Ruan J, Wang G, Zhang W. Characterization and identification of microRNA core promoters in four model species. PLoS Comput Biol 2007; 3: e37 [PMID: 17352530 DOI: 10.1371/journal.pcbi.0030037]
22. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-1966 [PMID: 15525708 DOI: 10.1261/rna.7135204]
23. Lund E, Güttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303: 95-98 [PMID: 14631048 DOI: 10.1126/science.1090599]
24. Okada C, Yamashita E, Lee SJ, Shibata S, Katahira J, Nakagawa A, Yoneda Y, Tsukihara T. A high-resolution structure of the pre-microRNA nuclear export machinery. Science 2009; 326: 1275-1279 [PMID: 19965479 DOI: 10.1126/science. 1178705]
25. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S, Kim VN. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-419 [PMID: 14508493 DOI: 10.1038/nature01957]
26. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005; 123: 631-640 [PMID: 16271387 DOI: 10.1016/j.cell.2005.10.022]
27. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63 [PMID: 18668040 DOI: 10.1038/nature07228]
28. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773 [PMID: 15685193 DOI: 10.1038/nature03315]
29. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
30. McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC, Friedman JR, Kaestner KH. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010; 139: 1654-1664, 1664. e1 [PMID: 20659473 DOI: 10.1053/j.gastro.2010.07.040]
31. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15: 563-568 [PMID: 16099643 DOI: 10.1016/j.gde.2005.08.005]
32. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27: 5959-5974 [PMID: 18836476 DOI: 10.1038/onc.2008.274]
33. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688 [PMID: 17898713 DOI: 10.1038/nature06174]
34. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833 [PMID: 15944707 DOI: 10.1038/nature03552]
35. Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 2009; 50: 506-509 [PMID: 19347736 DOI: 10.1080/10428190902763517]
36. Zabolotneva AA, Zhavoronkov AA, Shegay PV, Gaifullin NM, Alekseev BY, Roumiantsev SA, Garazha AV, Kovalchuk O, Aravin A, Buzdin AA. A systematic experimental evaluation of microRNA markers of human bladder cancer. Front Genet 2013; 4: 247 [PMID: 24298280 DOI: 10.3389/fgene.2013.00247]
37. Sandhu R, Rivenbark AG, Mackler RM, Livasy CA, Coleman WB. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer. Int J Oncol 2014; 44: 563-572 [PMID: 24297604 DOI: 10.3892/ ijo.2013.2197]
38. Roy R, De Sarkar N, Ghose S, Paul RR, Pal M, Bhattacharya C, Chowdhury SK, Ghosh S, Roy B. Genetic variations at microRNA and processing genes and risk of oral cancer. Tumour Biol 2014; 35: 3409-3414 [PMID: 24297336 DOI: 10.1007/ s13277-013-1450-3]
39. Sun F, Chen HG, Li W, Yang X, Wang X, Jiang R, Guo Z, Chen H, Huang J, Borowsky AD, Qiu Y. Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors. J Biol Chem 2014; 289: 1529-1539 [PMID: 24297183 DOI: 10.1074/jbc.M113.492140]
40. Yu H, Gao G, Jiang L, Guo L, Lin M, Jiao X, Jia W, Huang J. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 2013; 6: 2904-2911 [PMID: 24294377]
41. Lee HY, Mohammed KA, Kaye F, Sharma P, Moudgil BM, Clapp WL, Nasreen N. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer. Int J Nanomedicine 2013; 8: 4481-4494 [PMID: 24293999 DOI: 10.2147/IJN. S41782]
42. Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009; 32: 189-194 [PMID: 19303254 DOI: 10.1016/j.jaut.2009.02.012]
43. Sonkoly E, Pivarcsi A. Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med 2009; 13: 24-38 [PMID: 19175698 DOI: 10.1111/j.1582-4934.2008.00534.x]
44. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120-130 [PMID: 18204468 DOI: 10.1038/nri2252]
45. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007; 129: 303-317 [PMID: 17397913 DOI: 10.1016/j.cell.2007.03.030]
46. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116: 258-267 [PMID: 17606841 DOI: 10.1161/CIRCULATIONAHA.107.687947]
47. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005; 436: 214-220 [PMID: 15951802 DOI: 10.1038/nature03817]
48. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007; 13: 613-618 [PMID: 17468766 DOI: 10.1038/nm1582]
49. Zhu H, Shyh-Chang N, Segrè AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG, Urbach A, Thornton JE, Triboulet R, Gregory RI, Altshuler D, Daley GQ. The Lin28/let-7 axis regulates glucose metab olism. Cell 2011; 147: 81-94 [PMID: 21962509 DOI: 10.1016/ j.cell.2011.08.033]
50. Frost RJ, Olson EN. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc Natl Acad Sci USA 2011; 108: 21075-21080 [PMID: 22160727 DOI: 10.1073/pnas.1118922109]
51. Maes OC, Chertkow HM, Wang E, Schipper HM. MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders. Curr Genomics 2009; 10: 154-168 [PMID: 19881909 DOI: 10.2174/138920209788185252]
52. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135: 1624-1635. e24 [PMID: 18835392 DOI: 10.1053/j.gastro.2008.07.068]
53. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007; 13: 807-821 [PMID: 17262812 DOI: 10.1002/ibd.20110]
54. Bian Z, Li L, Cui J, Zhang H, Liu Y, Zhang CY, Zen K. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 2011; 225: 544-553 [PMID: 21590770 DOI: 10.1002/path.2907]
55. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146-159 [PMID: 17923094 DOI: 10.1016/j.cell.2007.07.021]
56. Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006; 68: 403-429 [PMID: 16460278 DOI: 10.1146/annurev.physiol.68.040104.131404]
57. Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol 2006; 16: 181-188 [PMID: 16537104 DOI: 10.1016/j.tcb.2006.02.006]
58. Angelow S, Ahlstrom R, Yu AS. Biology of claudins. Am J Physiol Renal Physiol 2008; 295: F867-F876 [PMID: 18480174 DOI: 10.1152/ajprenal.90264.2008]
59. Ye D, Guo S, Al-Sadi R, Ma TY. MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 2011; 141: 1323-1333 [PMID: 21763238 DOI: 10.1053/ j.gastro.2011.07.005]
60. Qin W, Ren Q, Liu T, Huang Y, Wang J. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett 2013; 587: 1434-1439 [PMID: 23523916 DOI: 10.1016/j.febslet.2013.03.023]
61. Li Q, Zhu F, Chen P. miR-7 and miR-218 epigenetically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast cancer. Biochem Biophys Res Commun 2012; 424: 28-33 [PMID: 22705304 DOI: 10.1016/ j.bbrc.2012.06.028]
62. Mishra R, Singh SK. HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. J Neurosci 2013; 33: 5992-6000 [PMID: 23554480 DOI: 10.1523/JNEUROSCI.4796-12.2013]
63. Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2010; 2: a002907 [PMID: 20182608 DOI: 10.1101/cshperspect.a002907]
64. Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, Keshavarzian A. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 2008; 32: 355-364 [PMID: 18162065 DOI: 10.1111/j.1530-0277.2007.00584.x]
65. Lu LF, Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009; 127: 291-298 [PMID: 19538248 DOI: 10.1111/j.1365-2567.2009.03092.x]
66. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86 [PMID: 14657504 DOI: 10.1126/science.1091903]
67. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080-7085 [PMID: 17438277 DOI: 10.1073/pnas.0702409104]
68. Dunne A, O'Neill LA. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett 2005; 579: 3330-3335 [PMID: 15876435 DOI: 10.1016/j.febslet.2005.04.024]
69. Kracht M, Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 2002; 20: 91-106 [PMID: 12453467]
70. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486 [PMID: 16885212 DOI: 10.1073/pnas.0605298103]
71. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocytederived dendritic cells. Proc Natl Acad Sci USA 2009; 106: 2735-2740 [PMID: 19193853 DOI: 10.1073/pnas.0811073106]
72. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-1609 [PMID: 17242365 DOI: 10.1073/pnas.0610731104]
73. Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, Saura R, Kurosaka M, Kumagai S. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 2009; 60: 1294-1304 [PMID: 19404929 DOI: 10.1002/art.24475]
74. Nagata Y, Nakasa T, Mochizuki Y, Ishikawa M, Miyaki S, Shibuya H, Yamasaki K, Adachi N, Asahara H, Ochi M. Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded MicroRNA-15a. Arthritis Rheum 2009; 60: 2677-2683 [PMID: 19714650 DOI: 10.1002/art.24762]
75. Otaegui D, Baranzini SE, Armañanzas R, Calvo B, Muñoz-Culla M, Khankhanian P, Inza I, Lozano JA, Castillo-Triviño T, Asensio A, Olaskoaga J, López de Munain A. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009; 4: e6309 [PMID: 19617918 DOI: 10.1371/journal.pone.0006309]
76. Padgett KA, Lan RY, Leung PC, Lleo A, Dawson K, Pfeiff J, Mao TK, Coppel RL, Ansari AA, Gershwin ME. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 2009; 32: 246-253 [PMID: 19345069 DOI: 10.1016/j.jaut.2009.02.022]
77. Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007; 16: 939-946 [PMID: 18042587 DOI: 10.11 77/0961203307084158]
78. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, Scheynius A, Ståhle M, Pivarcsi A. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2007; 2: e610 [PMID: 17622355 DOI: 10.1371/journal.pone.0000610]
79. Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010; 107: 14339-14344 [PMID: 20651252 DOI: 10.1073/pnas.0912701107]
80. Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berl) 2010; 88: 993-1001 [PMID: 20725711 DOI: 10.1007/s00109-010-0663-9]
81. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res 2008; 102: 401-414 [PMID: 18309108 DOI: 10.1161/CIRCRESAHA.107.165472]
82. West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 2011; 11: 389-402 [PMID: 21597473 DOI: 10.1038/nri2975]
83. Makino A, Scott BT, Dillmann WH. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 2010; 53: 1783-1794 [PMID: 20461356 DOI: 10.1007/ s00125-010-1770-4]
84. Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 2008; 28: 12581-12590 [PMID: 19020050 DOI: 10.1523/ JNEUROSCI.3338-08.2008]
85. Oba S, Kumano S, Suzuki E, Nishimatsu H, Takahashi M, Takamori H, Kasuya M, Ogawa Y, Sato K, Kimura K, Homma Y, Hirata Y, Fujita T. miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS One 2010; 5: e13614 [PMID: 21049046 DOI: 10.1371/journal.pone.0013614]
86. Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Mori RT, Hasegawa K, Kita T, Kimura T. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem 2010; 285: 4920-4930 [PMID: 20007690 DOI: 10.1074/jbc.M109.082610]
87. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762-765 [PMID: 19219026 DOI: 10.1038/nature07823]
88. Yuan C, Chen WX, Zhu JS, Chen NW, Lu YM, Ou YX, Chen HQ. IL-10 treatment is associated with prohibitin expression in the Crohn's disease intestinal fibrosis mouse model. Mediators Inflamm 2013; 2013: 617145 [PMID: 23690666 DOI: 10.1155/2013/617145]
89. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009; 43: 67-93 [PMID: 19653858 DOI: 10.1146/annurev-genet-102808-114910]
90. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-326 [PMID: 20144757 DOI: 10.1016/j.cell.2010.01.028]
91. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12: 99-113 [PMID: 19747213 DOI: 10.1111/j.1462-5822.2009.01381.x]
92. Kuballa P, Huett A, Rioux JD, Daly MJ, Xavier RJ. Impaired autophagy of an intracellular pathogen induced by a Crohn' s disease associated ATG16L1 variant. PLoS One 2008; 3: e3391 [PMID: 18852889 DOI: 10.1371/journal.pone.0003391]
93. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 2011; 27: 107-132 [PMID: 21801009 DOI: 10.1146/annurev-cellbio-092910-154005]
94. Noda T, Yoshimori T. Molecular basis of canonical and bactericidal autophagy. Int Immunol 2009; 21: 1199-1204 [PMID: 19737785 DOI: 10.1093/intimm/dxp088]
95. Lu C, Chen J, Xu HG, Zhou X, He Q, Li YL, Jiang G, Shan Y, Xue B, Zhao RX, Wang Y, Werle KD, Cui R, Liang J, Xu ZX. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology 2014; 146: 188-199 [PMID: 24036151 DOI: 10.1053/ j.gastro.2013.09.006]
96. Ghorpade DS, Sinha AY, Holla S, Singh V, Balaji KN. NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem 2013; 288: 33037-33048 [PMID: 24092752 DOI: 10.1074/ jbc.M113.492496]
97. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hébuterne X, Harel-Bellan A, Mograbi B, Darfeuille-Michaud A, Hofman P. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 2011; 43: 242-245 [PMID: 21278745 DOI: 10.1038/ng.762]
98. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269 [PMID: 16557279 DOI: 10.1038/nrc1840]
99. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC, Moreau R, Bouhnik Y, Laburthe M, Groyer A, Ogier-Denis E. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One 2010; 5: pii: e13160 [PMID: 20957151 DOI: 10.1371/journal.pone.0013160]
100. Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011; 53: 26-33 [PMID: 21546856 DOI: 10.1097/MPG.0b013e31822200cc]
101. Zhou R, Hu G, Gong AY, Chen XM. Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPSinduced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res 2010; 38: 3222-3232 [PMID: 20144951 DOI: 10.1093/nar/gkq056]
102. Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, Marabita F, Locati M, Spinelli A, Nos P, Invernizzi P, Danese S. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol 2013; 173: 250-258 [PMID: 23607522 DOI: 10.1111/cei.12104]
103. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-1694 [PMID: 23534542 DOI: 10.1056/NEJMoa1209026]
104. Misso G, Zappavigna S, Castellano M, De Rosa G, Di Martino MT, Tagliaferri P, Tassone P, Caraglia M. Emerging pathways as individualized therapeutic target of multiple myeloma. Expert Opin Biol Ther 2013; 13 Suppl 1: S95-109 [PMID: 23738692 DOI: 10.1517/14712598.2013.807338]
105. Rossi M, Pitari MR, Amodio N, Di Martino MT, Conforti F, Leone E, Botta C, Paolino FM, Del Giudice T, Iuliano E, Caraglia M, Ferrarini M, Giordano A, Tagliaferri P, Tassone P. miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. J Cell Physiol 2013; 228: 1506-1515 [PMID: 23254643 DOI: 10.1002/jcp.24306]
106. Amodio N, Leotta M, Bellizzi D, Di Martino MT, D'Aquila P, Lionetti M, Fabiani F, Leone E, Gullà AM, Passarino G, Caraglia M, Negrini M, Neri A, Giordano A, Tagliaferri P, Tassone P. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget 2012; 3: 1246-1258 [PMID: 23100393]
107. Amodio N, Di Martino MT, Foresta U, Leone E, Lionetti M, Leotta M, Gullà AM, Pitari MR, Conforti F, Rossi M, Agosti V, Fulciniti M, Misso G, Morabito F, Ferrarini M, Neri A, Caraglia M, Munshi NC, Anderson KC, Tagliaferri P, Tassone P. miR-29b sensitizes multiple myeloma cells to bortezomibinduced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis 2012; 3: e436 [PMID: 23190608 DOI: 10.1038/cddis.2012.175]